Christopher Charles Tarver, MD
Physical Medicine and Rehabilitation · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
- Since medical school
- 14 years
- Texas A & M University System, Hsc, College of Medicine, 2012
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Loma Linda University Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tarver’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126799 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · Texas A & M University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Loma Linda University Medical CenterLoma Linda, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Loma Linda University Health, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.47 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.146, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.468, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.383, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Loma Linda University Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.47 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.146 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.468 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.383 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.66 (0 to 1.53) · 2,053 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.35 (135.58 to 211.11) · 169 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 272 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,758 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,732 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.15 to 0.52) · 8,479 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.88 (1.14 to 4.63) · 2,571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.41) · 933 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.66 to 4.04) · 2,380 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.16 (0.2 to 10.13) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.42 (0.42 to 6.42) · 988 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.91 to 3.67) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 0.85) · 7,115 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 37 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.685 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.702 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 380 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 660 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.1 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 29.6 · 365 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.5 · 282 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 513 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (4 to 7.3) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (10.2 to 15.5) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 18.1) · 720 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 778 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,684 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$40,838
Medicare paid this office $40,838 for 145 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $8,930 | $60 |
| New patient visit (60+ min) | 23 | $3,747 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,050 | $109 |
| Short return visit (20+ min) | 27 | $2,031 | $66 |
| Return visit (30+ min) | 19 | $1,840 | $80 |
See all 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $8,930 | $60 |
| New patient visit (60+ min) | 23 | $3,747 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,050 | $109 |
| Short return visit (20+ min) | 27 | $2,031 | $66 |
| Return visit (30+ min) | 19 | $1,840 | $80 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 14 | $1,689 | $94 |
| New patient visit (45+ min) | 12 | $1,435 | $120 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 11 | $1,204 | $86 |
| Return visit (30+ min) | 12 | $1,053 | $88 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 13 | $1,052 | $53 |
| Hospital discharge day management, 30 minutes or less | 13 | $840 | $65 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 16 | 34 | 33 | 38 | 34 | 20 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 16 | 23 | 24 | 25 | 20 | 14 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 17 | 23 | – | – | 22 | 18 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
145 Original Medicare patients in 2024. Average age 66 · Under 65 32% · 85 and older 12% · Women 48% · Also on Medicaid 48% · Health risk score 2.44. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Stroke 50% · Diabetes 39% · Chronic kidney disease 37% · Depression 36% · Coronary heart disease 31% · Heart failure 30% · Atrial fibrillation 23% · Dementia 21% · COPD 14% · Cancer 12%.
The office billed $174,599, Medicare allowed $53,706 and paid $40,838; for 482 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 145 | 482 | 66 | 2.44 | $174,599 | $40,838 |
| 2023 | 132 | 861 | 66 | 2.02 | $247,071 | $65,869 |
| 2022 | 125 | 808 | 64 | 2.58 | $239,387 | $60,674 |
| 2021 | 124 | 901 | 62 | 2.44 | $258,609 | $67,775 |
| 2020 | 148 | 920 | 64 | 2.35 | $260,554 | $67,654 |
| 2019 | 226 | 4,678 | 67 | 2.39 | $330,660 | $83,994 |
| 2018 | 336 | 8,729 | 69 | 2.74 | $393,402 | $99,724 |
| 2017 | 394 | 2,824 | 71 | 2.91 | $296,023 | $75,614 |
| 2016 | 168 | 334 | 69 | 2.53 | $115,270 | $31,311 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $26,033 | $64 |
| Return visit (30+ min) | 34 | $5,314 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $3,797 | $105 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,696 | $66 |
| Short return visit (20+ min) | 26 | $2,083 | $56 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 11 | $1,901 | $86 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 14 | $1,865 | $55 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 11 | $1,557 | $78 |
| Ultrasonic guidance for needle placement | 19 | $984 | $23 |
2022: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $22,013 | $58 |
| Return visit (30+ min) | 32 | $4,095 | $80 |
| Short return visit (20+ min) | 32 | $3,218 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,654 | $111 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 14 | $2,181 | $87 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 15 | $2,141 | $56 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,592 | $59 |
| Ultrasonic guidance for needle placement | 20 | $1,050 | $24 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $27,124 | $60 |
| Return visit (30+ min) | 36 | $6,285 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,569 | $112 |
| Short return visit (20+ min) | 32 | $2,760 | $66 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 14 | $2,045 | $85 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 14 | $1,893 | $57 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,518 | $61 |
| Ultrasonic guidance for needle placement | 21 | $1,151 | $26 |
2020: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $26,280 | $61 |
| Return visit (30+ min) | 45 | $4,927 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,411 | $113 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,651 | $62 |
| Short return visit (20+ min) | 29 | $2,115 | $59 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 17 | $1,962 | $58 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 16 | $1,856 | $81 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 11 | $1,835 | $80 |
| Ultrasonic guidance for needle placement | 22 | $1,036 | $25 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $676 | $61 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $22,929 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 86 | $10,045 | $107 |
| Return visit (30+ min) | 59 | $6,543 | $84 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 16 | $1,676 | $99 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,620 | $81 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 12 | $1,439 | $90 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,393 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $1,070 | $31 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 12 | $958 | $60 |
| Short return visit (20+ min) | 11 | $808 | $62 |
| Ultrasonic guidance for needle placement | 23 | $774 | $27 |
2018: 10 services
| Botox | 16 | $38,557 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 196 | $22,854 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $8,334 | $58 |
| Return visit (30+ min) | 41 | $4,919 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,614 | $163 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 12 | $2,461 | $117 |
| Short return visit (20+ min) | 23 | $1,826 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 49 | $1,695 | $31 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,640 | $82 |
| Ultrasonic guidance for needle placement | 13 | $504 | $27 |
2017: 8 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 227 | $26,193 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $11,367 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $10,971 | $161 |
| Return visit (30+ min) | 40 | $4,201 | $81 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 49 | $1,633 | $31 |
| Short return visit (20+ min) | 23 | $1,621 | $56 |
| Long return visit (40+ min) | 14 | $1,236 | $88 |
| Hospital discharge day management, 30 minutes or less | 12 | $605 | $50 |
2016: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $11,188 | $162 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,644 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,390 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 46 | $2,419 | $32 |
Medicaid work
$16,953 in 2024
Medicaid paid $16,953 for 275 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 275 | $16,953 |
| 2024 | 275 | 1 | 19 | $16,953 |
| 2023 | 329 | 2 | 16 | $22,817 |
| 2022 | 132 | 1 | 12 | $8,138 |
| 2021 | 60 | 1 | 12 | $1,856 |
| 2020 | 12 | 1 | 12 | $1,003 |
| 2019 | 80 | 2 | 16 | $4,880 |
| 2018 | 187 | 3 | 16 | $11,151 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 303 | $20,501 |
| Return visit (30+ min) | 26 | $2,315 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 132 | $8,138 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 60 | $1,856 |
2020
| Return visit (30+ min) | 12 | $1,003 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 52 | $2,523 |
| Return visit (30+ min) | 28 | $2,357 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 115 | $5,200 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 58 | $3,153 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $2,798 |
Drugs they prescribed that Part D paid
$18,472
Pharmacies billed $18,472 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 386) in 2024. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
344 generic and fewer than 11 brand-name prescriptions · $18,472 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Baclofen | 70 | $3,122 | $45 |
| Gabapentin | 36 | $1,016 | $28 |
| Methocarbamol | 15 | $587 | $39 |
| Tizanidine | 12 | $318 | $27 |
| Fluoxetine | 13 | $242 | $19 |
See all 8 drugs
| Baclofen | 70 | $3,122 | $45 |
| Gabapentin | 36 | $1,016 | $28 |
| Methocarbamol | 15 | $587 | $39 |
| Tizanidine | 12 | $318 | $27 |
| Fluoxetine | 13 | $242 | $19 |
| Diazepam | 19 | $229 | $12 |
| Amlodipine Besylate | 12 | $43 | $4 |
| Atorvastatin | 13 | $39 | $3 |
Year by year
| 2024 | 386 | 75 | 3% (13) | None | $18,472 |
| 2023 | 702 | 90 | 2% (16) | 9% | $61,288 |
| 2022 | 654 | 82 | None | None | $34,134 |
| 2021 | 644 | 86 | None | None | $34,348 |
| 2020 | 704 | 95 | 4% (25) | None | $57,326 |
| 2019 | 500 | 68 | 4% (19) | None | $32,236 |
| 2018 | 325 | 34 | None | 6% | $19,334 |
| 2017 | 240 | 38 | 10% (23) | 21% | $22,233 |
| 2016 | 67 | 13 | None | 18% | $5,854 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Baclofen | 96 | $6,242 | $65 |
| Gabapentin | 58 | $2,736 | $47 |
| Tizanidine | 41 | $1,870 | $46 |
| Dantrolene | 14 | $1,315 | $94 |
| Duloxetine | 11 | $1,167 | $106 |
| Methocarbamol | 15 | $949 | $63 |
| Diclofenac | 22 | $947 | $43 |
| Atorvastatin | 37 | $485 | $13 |
| Tamsulosin | 15 | $238 | $16 |
| Diazepam | 22 | $234 | $11 |
| Trazodone | 13 | $230 | $18 |
| Amlodipine Besylate | 16 | $207 | $13 |
| Famotidine | 17 | $198 | $12 |
| Brimonidine | 11 | $161 | $15 |
| Pantoprazole | 12 | $144 | $12 |
| Benazepril | 11 | $108 | $10 |
| Losartan | 12 | $101 | $8 |
2022: 14 drugs
| Baclofen | 105 | $6,154 | $59 |
| Gabapentin | 82 | $3,705 | $45 |
| Dantrolene | 12 | $1,490 | $124 |
| Tizanidine | 60 | $1,328 | $22 |
| Diclofenac | 26 | $1,114 | $43 |
| Methocarbamol | 37 | $889 | $24 |
| Midodrine | 18 | $727 | $40 |
| Atorvastatin | 30 | $274 | $9 |
| Fluoxetine | 13 | $273 | $21 |
| Amitriptyline | 13 | $174 | $13 |
| Diazepam | 18 | $125 | $7 |
| Famotidine | 14 | $112 | $8 |
| Benazepril | 15 | $103 | $7 |
| Amlodipine Besylate | 12 | $57 | $5 |
2021: 12 drugs
| Baclofen | 122 | $7,703 | $63 |
| Diclofenac | 29 | $1,664 | $57 |
| Tizanidine | 52 | $1,629 | $31 |
| Gabapentin | 96 | $1,289 | $13 |
| Dantrolene | 12 | $859 | $72 |
| Methocarbamol | 32 | $848 | $26 |
| Midodrine | 13 | $456 | $35 |
| Amitriptyline | 12 | $446 | $37 |
| Atorvastatin | 22 | $182 | $8 |
| Benazepril | 14 | $77 | $6 |
| Trazodone | 11 | $70 | $6 |
| Diazepam | 11 | $43 | $4 |
2020: 16 drugs
| Baclofen | 120 | $9,065 | $76 |
| Myrbetriq | 11 | $4,783 | $435 |
| Diclofenac | 42 | $4,527 | $108 |
| Dantrolene | 32 | $2,565 | $80 |
| Tizanidine | 18 | $1,133 | $63 |
| Methocarbamol | 18 | $648 | $36 |
| Gabapentin | 58 | $644 | $11 |
| Oxybutynin Chloride Er | 14 | $476 | $34 |
| Amitriptyline | 14 | $458 | $33 |
| Atorvastatin | 27 | $222 | $8 |
| Trazodone | 19 | $196 | $10 |
| Tamsulosin | 11 | $120 | $11 |
| Clopidogrel | 12 | $95 | $8 |
| Amlodipine Besylate | 17 | $77 | $5 |
| Benazepril | 16 | $64 | $4 |
| Diazepam | 12 | $42 | $3 |
2019: 10 drugs
| Baclofen | 132 | $9,187 | $70 |
| Myrbetriq | 11 | $4,561 | $415 |
| Tizanidine | 23 | $1,980 | $86 |
| Diclofenac | 20 | $1,732 | $87 |
| Gabapentin | 48 | $946 | $20 |
| Oxybutynin Chloride Er | 17 | $659 | $39 |
| Methocarbamol | 17 | $318 | $19 |
| Diazepam | 12 | $167 | $14 |
| Atorvastatin | 16 | $130 | $8 |
| Trazodone | 12 | $91 | $8 |
2018: 6 drugs
| Baclofen | 129 | $6,240 | $48 |
| Tizanidine | 35 | $3,797 | $108 |
| Gabapentin | 33 | $1,169 | $35 |
| Amitriptyline | 11 | $417 | $38 |
| Methocarbamol | 11 | $123 | $11 |
| Trazodone | 14 | $53 | $4 |
2017: 6 drugs
| Tizanidine | 18 | $4,552 | $253 |
| Baclofen | 72 | $4,085 | $57 |
| Methenamine Hippurate | 13 | $1,230 | $95 |
| Amitriptyline | 13 | $455 | $35 |
| Hydrocodone-Acetaminophen | 17 | $293 | $17 |
| Trihexyphenidyl | 16 | $150 | $9 |
2016: 1 drug
| Baclofen | 16 | $946 | $59 |
Money from drug and device companies
$54 in 2023
| 2023 | 1 | 2 | None | $54 |
| 2022 | 1 | 1 | None | $13 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Botox | $54 | 2 payments
|
See all 2 published payments
| AbbVie | Meals · 2023-10-04 | Botox | $26 |
| AbbVie | Meals · 2023-01-18 | Botox | $28 |
See earlier years (2022, 2019)
2022: $13
| Abbvie | Botox | $13 | 1 payment
|
2019: $16
| Allergan | Botox | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1730448689
- Licence
- CA A126799California A126799: Current · expires 2027-05-31
- Trained
- Texas A & M University System, Hsc, College of Medicine, 2012 · 14 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X); Federal specialty code 2081P0301X (2081P0301X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-05-13
- NPI last updated
- 2024-07-02
- NPI record certified
- 2024-07-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 11234 Anderson St, Loma Linda, CA, 92354